Delivery Order SPE2DE21D7020-SPE2D626F2078
- Not listed
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $11,312.43 by the Defense Health Agency's Medical Supply Chain program. The contract, awarded on August 14, 2025, with an ultimate completion date of August 21, 2025, utilizes fixed-price pricing with economic price adjustment. The delivery order is to be performed at Boston Scientific's facility in Marlborough, MA, and no small business set-aside...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $1,117.24 by the Defense Health Agency's Medical Supply Chain program. This fixed-price contract with economic price adjustment is scheduled for completion by September 16, 2025, and will be performed at the company's facility in Marlborough, MA. The contract represents a continuation of Boston Scientific's established role as a prime contractor...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $6,118.95 by the Defense Health Agency's Medical Supply Chain on September 16, 2025. This fixed-price contract with economic price adjustment provisions has an ultimate completion date of September 23, 2025 and carries no set-aside designation, indicating open competition in the federal marketplace. The work will be performed at Boston Scientific's...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a fixed-price delivery order valued at $12,317.30 by the Defense Health Agency's Medical Supply Chain division. The delivery order, designated as a non-set-aside contract with an ultimate completion date of August 27, 2025, represents a continuation of Boston Scientific's role as a critical supplier of advanced medical devices to federal healthcare agencies. The contract is...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $13,027.08 by the Defense Health Agency's Medical Supply Chain on August 4, 2025. The contract, which utilizes fixed-price pricing with economic price adjustment, is scheduled for completion by August 11, 2025. The award represents a non-set-aside competitive procurement, and the place of performance is Boston Scientific's facility in Marlborough, MA. As...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $4,505.50 by the Defense Health Agency's Medical Supply Chain on August 5, 2025. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of August 12, 2025 and involves performance at Boston Scientific's facility in Marlborough, MA. The award was made without a set-aside designation, allowing the company...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $75,560 by the Defense Health Agency's Medical Supply Chain on August 20, 2025, with an ultimate completion date of September 10, 2025. This fixed-price contract with economic price adjustment provisions represents a non-competitive award with no small business set-aside. As the place of performance is Boston Scientific's headquarters location in...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $1,416.45 by the Defense Health Agency's Medical Supply Chain on July 29, 2025. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 5, 2025, and will be performed at Boston Scientific's facility in Marlborough, MA. The award uses no set-aside designation, allowing Boston Scientific to compete openly...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $6,593.05 by the Defense Health Agency's Medical Supply Chain on August 28, 2025. This fixed-price contract with economic price adjustment provisions is scheduled for completion by September 5, 2025, and will be performed at Boston Scientific's facility in Marlborough, MA. The award represents a continuation of Boston Scientific's role as a critical...
- Boston Scientific Corp, a major global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $32,850 by the Defense Health Agency's Medical Supply Chain under contract 4569047952. This fixed-price delivery order with economic price adjustment terms carries an ultimate completion date of August 18, 2025, and was issued on August 11, 2025. The contract is not set-aside and represents Boston Scientific's continued role as a prime...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D626F2078Delivery Order
Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $29,701.08 by the Defense Health Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment authority is scheduled for completion by October 23, 2025, and represents work to be performed at the contractor's facility in Marlborough, MA. The award was issued without small business set-aside provisions, allowing Boston Scientific to compete on an unrestricted basis. This delivery order is issued against Boston Scientific's existing blanket purchase agreement with the Defense Health Agency, a single-award indefinite delivery vehicle valued at $750,000 with a ceiling through March 30, 2030, which was established specifically for the provision of radiation treatment devices. Boston Scientific's BPA and associated delivery orders support the Defense Health Agency's and Veterans Affairs' critical requirements for specialized radiation oncology equipment and therapies, including yttrium-90 glass microspheres and related radiopharmaceuticals used in cancer treatment across military healthcare facilities and VA medical centers. The contractor's established capability to deliver complex medical devices while maintaining supply chain continuity for specialized treatment modalities has positioned it as the sole supplier under this IDV structure, enabling streamlined and rapid resupply of advanced radiation treatment technologies essential to federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.7k | 10/16/25 |